CardioPractice Cardio Talk

European Society of Cardiology
undefined
Apr 1, 2024 • 9min

Artificial intelligence in Imaging algorithms - what is used in clinical routine?

With João Bicho Augusto, Hospital Professor Doutor Fernando Fonseca, Amadora - Portugal, Institute of Cardiovascular Science, University College London, London - United Kingdom & Victoria Johnson, University Hospital Frankfurt, Frankfurt am Main - Germany. In this podcast, Dr João Bicho Augusto (Hospital Professor Doutor Fernando Fonseca, Amadora, Portugal & Institute of Cardiovascular Science, University College London, London, United Kingdom) joins Dr Victoria Johnson (University Hospital Frankfurt, Frankfurt am Main, Germany) to discuss his CardioPractice article: Artificial intelligence in cardiovascular imaging algorithms - what is used in clinical routine?
undefined
Mar 5, 2024 • 11min

Hypertriglyceridaemia and residual cardiovascular risk.

With Dimitris RICHTER, Euroclinic of Athens, Athens - Greece & Heinz DREXEL, Vorarlberg Institute for Vascular Investigation and Treatment, Feldkirch - Austria. In this podcast, Professor Heinz Drexel (Vorarlberg Institute for Vascular Investigation and Treatment, Feldkirch, Austria) joins Dr Dimitris Richter (Euroclinic of Athens, Athens, Greece) to discuss hypertriglyceridemia and residual cardiovascular risk.   Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk. N Engl J Med. 2022 Nov 24;387(21):1923-1934. Sosnowska B, Adach W, Surma S, Rosenson RS, Banach M. Evinacumab, an ANGPTL3 Inhibitor, in the Treatment of Dyslipidemia. J Clin Med. 2022 Dec 25;12(1):168. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821629/ Gaba P, Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Juliano RA, Jiao L, Doyle RT Jr, Granowitz C, Tardif JC, Giugliano RP, Martens FMAC, Gibson CM, Ballantyne CM; REDUCE-IT Investigators. Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction. J Am Coll Cardiol. 2022 May 3;79(17):1660-1671. https://www.sciencedirect.com/science/article/pii/S0735109722005538?via%3Dihub Drexel H, Tamargo J, Kaski JC, Lewis BS, Saely CH, Fraunberger P, Dobrev D, Komiyama M, Plattner T, Agewall S, Hasegawa K. Triglycerides revisited: is hypertriglyceridaemia a necessary therapeutic target in cardiovascular disease? Eur Heart J Cardiovasc Pharmacother. 2023 Sep 20;9(6):570-582. https://academic.oup.com/ehjcvp/article/9/6/570/7199773?login=false ACCORD Study Group; Ginsberg HN, Elam MB, Lovato LC, Crouse JR 3rd, Leiter LA, Linz P, Friedewald WT, Buse JB, Gerstein HC, Probstfield J, Grimm RH, Ismail-Beigi F, Bigger JT, Goff DC Jr, Cushman WC, Simons-Morton DG, Byington RP. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med. 2010 Apr 29;362(17):1563-74. https://www.nejm.org/doi/10.1056/NEJMoa1001282?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200www.ncbi.nlm.nih.gov
undefined
Mar 5, 2024 • 7min

Lipids and diabetes

With Nicolaus Marx, WTH University Hospital Aachen, Aachen - Germany & Ruxandra Christodorescu, University of Medicine and Pharmacy Victor Babes, Timisoara - Romania.   In this podcast, Professor Nicolaus Marx (WTH University Hospital Aachen, Aachen, Germany), Chair of Task Force of the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes;  joins Associate Professor Ruxandra Christodorescu (University of Medicine and Pharmacy Victor Babes, Timisoara, Romania) to discuss lipids and diabetes.
undefined
Feb 6, 2024 • 13min

(Part 1) Sudden cardiac death and sport cardiology: multimodality imaging in cardiomyopathies

Dr. Harald Jorstad and Dr. Maria Sanz de la Garza discuss the role of imaging in diagnosing cardiomyopathies and coronary artery disease, and the challenges in evaluating athletes. They highlight the use of echocardiography and CMR for diagnosis, identification of pathological features, and differentiation between cardiomyopathies. The evaluation of myocardial patterns, including diastolic function and hypertrophy mechanical dispersion, is also explored.
undefined
Feb 6, 2024 • 8min

(Part 2) Sudden cardiac death and sport cardiology: multimodality imaging in aortopathies and ischemic heart disease

With Harald Jorstad, Amsterdam UMC - The Netherlands and Maria Sanz de la Garza, Hospital Clinic Barcelona, Barcelona - Spain.    In the second of two podcasts, Dr Harald Jorstad (Amsterdam UMC, the Netherlands) joins Dr Maria Sanz de la Garza (Hospital Clínic de Barcelona, Barcelona, Spain) to discuss the role of imaging for the prevention of sudden cardiac death with a focus on multimodality imaging in aortopathies and ischaemic heart disease. 
undefined
Feb 6, 2024 • 17min

Risk stratification in sports cardiology

With Harald Jorstad, Amsterdam UMC - The Netherlands and Michael Papadakis, St. George’s, University of London and St George’s Hospitals NHS Foundation Trust, London - UK.      In this podcast, Dr Harald Jorstad (Amsterdam UMC, The Netherlands) is joined by Professor Michael Papadakis (St. George’s, University of London and St George’s Hospitals NHS Foundation Trust, London, UK) to discuss risk stratification in sports cardiology. 
undefined
Jan 9, 2024 • 13min

Exercise prescription in athletes with cardiomyopathies

With Harald Thune Jørstad (host), Amsterdam UMC, Amsterdam - The Netherlands & Flavio D'Ascenzi, University of Siena, Siena - Italy. In this podcast, Dr Harald Thune Jørstad (Amsterdam UMC, Amsterdam, The Netherlands) and Assoc. Prof. Flavio D’Ascenzi (University of Siena, Siena, Italy) discuss exercise prescription in athletes with cardiomyopathies.
undefined
Jan 9, 2024 • 10min

Physical exercising for cardiovascular prevention

With Harald Thune Jørstad (host), Amsterdam UMC, Amsterdam - The Netherlands, Jolien Roos-Hesselink2, Erasmus MC, Rotterdam -The Netherlands  & Dr.Martijn Kauling, Erasmus MC, Rotterdam - The Netherlands. In this podcast, Dr Harald Thune Jørstad (Amsterdam UMC, Amsterdam, The Netherlands), Prof. Jolien Roos-Hesselink and Dr.Martijn Kauling (Erasmus MC, Rotterdam, The Netherlands) discuss physical exercising for cardiovascular prevention.
undefined
Dec 7, 2023 • 13min

Tricuspid insufficiency for the general cardiologist

Cardiologist Stefano Nistri and professor Luigi P. Badano discuss tricuspid insufficiency for general cardiologists, exploring its prevalence, impact, and factors contributing to its development. They emphasize the importance of evaluating the right atrium and differentiating tricuspid regurgitation from pulmonary hypertension. Accurate measurements and assessment of tricuspid insufficiency in echocardiograms are crucial. The podcast also covers the evaluation, referral, and treatment processes for tricuspid insufficiency and related issues in the aorta and atrium.
undefined
Nov 3, 2023 • 13min

Aortic coarctation: from imaging to comprehensive long-term care

With Damien Cullington, Liverpool Heart and Chest Hospital, Liverpool - UK & Julie De Backer, University Hospital Ghent, Ghent - Belgium.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app